Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

1. Canaani, J.
2. Labopin, M.
3. Huang, X.J.
4. Ciceri, F.
5. Van Lint, M.T.
6. Bruno, B.
7. Santarone, S.
8. Diez-Martin, J.L.
9. Blaise, D.
10. Chiusolo, P.
11. Wu, D.
12. Mohty, M.
13. Nagler, A.